Company Overview

Development Stage

About the Company

[Summary] 专注于siRNA药物的开发

舶望制药是一家处于临床阶段的生物技术公司,致力于开发新一代siRNA药物,为全球患者提供更好的治疗手段。在过去的四年里,舶望制药利用其*的RADS(更强活性、持久性和安全性的RNA分子)平台技术,建立了丰富且差异化的siRNA候选药物管线,涵盖广泛的适应症。在经验丰富的专业团队的领导下,舶望制药在siRNA药物发现方面展现了卓越的科学性,并在将潜在治疗产品从发现阶段推进到临床阶段方面展现了强大的执行力。

Expand
Information is aggregated from the web and may not be exact. For reference only.
Information incorrect? Claim this company to edit

舶望制药 Financing History (1 rounds)

Manage
A+轮
Capital Market Favor
Latest Financing Round
  • Date: ?
  • Amount: 3亿人民币
  • Investor: 国投招商,华盖资本,三一创...

舶望制药 How Fast Is Hiring Growing? (114 open positions)

Manage
Note: How fast is hiring at 上海舶望制药有限公司 growing? 舶望制药2025: 26 openings (down 10%), 2024: 29 openings (up 71%), 2023: 17 openings (up 42%), 2022: 12 openings (up 300%), 2021: 3 openings. A rising curve may indicate expansion; a falling curve may indicate slower growth or good retention. Based on publicly available data, for reference only.

舶望制药 Master's Degree Job Demand Analysis

(More)
?
Growth Rate
2026 vs 2025
  • 2025: Up 11%
  • 2024: Up 80%
  • 2023: Flat 0%-
舶望制药 Master's Hiring by Year:
* Hiring was generally low during 2020-2022 due to the pandemic
How fast is master's hiring at 上海舶望制药有限公司 growing? 舶望制药Master's recruitment over the years: 2025: 10 openings (up 11%), 2024: 9 openings (up 80%), 2023: 5 openings (flat), 2022: 5 openings.

舶望制药 Doctoral Degree Job Demand Analysis

(More)
+257%
Growth Rate
2026 vs 2025
  • 2025: Up 40%
  • 2024: Up 67%
  • 2023: Up 200%
舶望制药 Doctoral Hiring by Year: 2026 — 18 more jobs than 2025
* Hiring was generally low during 2020-2022 due to the pandemic
How fast is doctoral hiring at 上海舶望制药有限公司 growing? 舶望制药Doctorate recruitment over the years: 2026: 25 openings (up 257%), 2025: 7 openings (up 40%), 2024: 5 openings (up 67%), 2023: 3 openings (up 200%), 2022: 1 openings.

舶望制药 R&D Strength (Technical Talent Demand)

(More)
How is the demand for technical talent at 上海舶望制药有限公司? Based on an analysis of 舶望制药's job postings over the past year, "科研类" demand: 54.1%, "生物/制药/化工/环保类": 47.1%, "医疗卫生/美容保健类": 17.8%, "计算机/网络/技术类": 5.7%, "其他(研发和技术类)": 1.3%, "电子/电器/通信技术类": 1.3%. For reference only.

舶望制药 — What Are the Salaries Like? (157 records)

Manage
salary range: 2K - 50K, 48.5% of roles pay ¥20-50K
Note: salary statistics are based on 157 salary records from the past year and depend on the job sample. For reference only.
How is the salary at 上海舶望制药有限公司?舶望制药48.5% of positions earn 20-50K, Fresh graduate salary: ¥8.4K。科研类 average salary ¥24.8K。 Note: Based on analysis of job postings, does not represent current on-the-job positions; system stability may affect objectivity. For reference only.Data inaccurate? Let us know

Salaries for hot jobs of 舶望制药

(More)
Are salaries high at 上海舶望制药有限公司? We provide: 科学家,生物科学,高级经理,oc,分析,副总,项目管理,实习生,ie,qa,机工,ir,ma,cto,pa,pm,ra,临床,培训,bi. Click to view detailed salary analysis by job.

舶望制药 honors, qualifications & industry associations

舶望制药 Related Industry Tags

Job Category

  • 科研类
    50.8% of total 50.8%
  • 生物/制药/化工/环保类
    44.8% of total 44.8%
  • 经营管理类
    24.3% of total 24.3%
  • 医疗卫生/美容保健类
    19.3% of total 19.3%

Education

  • 本科
    39.8% of total 39.8%
  • 硕士
    34.8% of total 34.8%
  • 博士
    13.8% of total 13.8%
  • 大专
    7.7% of total 7.7%

Experience

  • 5-10年
    34.8% of total 34.8%
  • 3-5年
    27.6% of total 27.6%
  • 1-3年
    17.7% of total 17.7%
  • 不限
    17.7% of total 17.7%
View Detailed Analysis

What does 上海舶望制药有限公司 require? Who is 舶望制药 hiring? 舶望制药 recruitment: 科研类占比最多占50.8%,其次是生物/制药/化工/环保类占44.8%. What education can get in at 舶望制药? 本科占比最多占39.8%,其次是硕士占34.8%. High education required at 舶望制药? 硕士占34.8%,博士占13.8%. Work experience required at 舶望制药? 5-10年占比最多占34.8%,其次是3-5年占27.6%. Where are the job locations at 舶望制药? 上海占比最多占100%. Based on job postings from the past year, for reference only.

Business Registration

Provided by

Operating Status: 开业
Registered Capital: 74,542.8464万(元)
Legal Representative: 舒东旭
Date Established:
Credit Code: 91310114MA1GXWAR5R
Registered Address: 上海市嘉定区江桥镇沙河路337号1_203室J2026

Partners & Suppliers

舶望制药授予诺华针对心血管疾病的RNAi疗法项目的全球独家许可,以及针对多个心血管和代谢靶点的RNAi项目的合作选择权。诺华支付首付款、期权费及里程碑付款,舶望保留部分项目权益。 Source
合作客户 战略合作/技术许可

People who follow 舶望制药 also follow

舶望制药 Competitors (Similar Companies)

“Promoting human health”
“We focus on scientific innovation, exploring, developing, and providin”
“In the rapidly growing biopharmaceutical field, accelerate and transfo”
“Research, development, and production of anti-tumor and surgical medic”
“Dedicated to the research, development, production, and commercializat”
“A leader in the diabetes field”
“Continuously innovating to bring patients medicines that significantly”
“Focused on three major fields: healthcare, life science, and electroni”
“An innovative biopharmaceutical enterprise focusing on antibody drugs”
制药/药业 药物研发 医药工业 抗肿瘤药
制药/药业 抗肿瘤药 肿瘤检测 神经系统疾病药物
“一家以基因治疗药物研发为核心的生物医药创新研发企业”
“抗体偶联药物(ADC)等生物偶联药端到端服务”
“Helping patients access more effective medicines sooner”
“High-end prescription drugs, interventional medical devices”

Report

*Reason:

Radical political or ideological topics
Advertising or spam
Pornographic or vulgar content
Obscene language or personal attacks
Other

Congratulations, submitted successfully!

Your edit is under review. You will be notified by email within 1 business day.

Submission failed.

Followed successfully. We'll notify you of any company updates.

Help others learn about this company, add my impression of this company»

Log in with the following accounts to save your follows

Followed successfully, we'll notify you of any company updates